Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1972 1
1977 1
1980 2
1981 3
1982 1
1983 5
1984 6
1985 8
1986 5
1987 13
1988 20
1989 28
1990 40
1991 39
1992 57
1993 94
1994 105
1995 119
1996 148
1997 132
1998 158
1999 170
2000 215
2001 190
2002 213
2003 253
2004 280
2005 323
2006 419
2007 431
2008 510
2009 548
2010 667
2011 684
2012 713
2013 698
2014 745
2015 735
2016 673
2017 606
2018 567
2019 543
2020 562
2021 532
2022 437
2023 368
2024 165

Text availability

Article attribute

Article type

Publication date

Search Results

11,787 results

Results by year

Filters applied: . Clear all
Page 1
Breast cancer pharmacogenetics: a systematic review.
Scudeler MM, Manóchio C, Braga Pinto AJ, Santos Cirino HD, da Silva CS, Rodrigues-Soares F. Scudeler MM, et al. Pharmacogenomics. 2023 Jan;24(2):107-122. doi: 10.2217/pgs-2022-0144. Epub 2022 Dec 8. Pharmacogenomics. 2023. PMID: 36475975 Review.
Breast cancer was declared the most prevalent type of cancer in 2020. Among other factors, treatment response can be affected by genetic polymorphisms - which is the focus of pharmacogenetics - and ethnicity is also a contributing factor in this …
Breast cancer was declared the most prevalent type of cancer in 2020. Among other factors, treatment response can be af …
Polymorphism of lncRNAs in breast cancer: Meta-analysis shows no association with susceptibility.
Mathias C, Garcia LE, Teixeira MD, Kohler AF, Marchi RD, Barazetti JF, Gradia DF, de Oliveira JC. Mathias C, et al. J Gene Med. 2020 Dec;22(12):e3271. doi: 10.1002/jgm.3271. Epub 2020 Oct 12. J Gene Med. 2020. PMID: 32889751 Review.
Only a small portion of lncRNAs are functionally characterized, and several approaches have been proposed for investigating the roles of these molecules, including how polymorphisms in lncRNA genomic sites may interfere with their function. Allele frequency variation in si …
Only a small portion of lncRNAs are functionally characterized, and several approaches have been proposed for investigating the roles of the …
Review of Polymorphism of the Calcium-Sensing Receptor Gene and Breast Cancer Risk.
Campos-Verdes LM, Costa-Silva DR, da Silva-Sampaio JP, Barros-Oliveira MDC, Escórcio-Dourado CS, Martins LM, Sampaio FA, Revoredo C, Alves-Ribeiro FA, da Silva BB. Campos-Verdes LM, et al. Cancer Invest. 2018 Feb 7;36(2):1-7. doi: 10.1080/07357907.2018.1430817. Epub 2018 Mar 5. Cancer Invest. 2018. PMID: 29504802 Review.
Polymorphism of the calcium-sensing receptor gene (CaSR or CaR) has been associated with an increased risk for breast cancer. ...Likewise, some studies have supported not only an association between calcium receptor gene polymorphism and breast …
Polymorphism of the calcium-sensing receptor gene (CaSR or CaR) has been associated with an increased risk for breast cance …
Insulin-like Growth Factor 1 gene polymorphism and breast cancer risk.
Costa-Silva DR, Barros-Oliveira MD, Borges RS, Tavares CB, Borges US, Alves-Ribeiro FA, Silva VC, Silva BB. Costa-Silva DR, et al. An Acad Bras Cienc. 2016 Oct-Dec;88(4):2349-2356. doi: 10.1590/0001-3765201620160169. Epub 2016 Dec 1. An Acad Bras Cienc. 2016. PMID: 27925035 Free article. Review.
Insulin-like Growth Factor-1 (IGF-1) gene polymorphism has been associated with an increased risk for breast cancer. ...This review aims to present the recent finds of IGF-1 gene polymorphism and its relationship with the risk of breast cance …
Insulin-like Growth Factor-1 (IGF-1) gene polymorphism has been associated with an increased risk for breast cancer. .. …
Genetic polymorphism of matrix metalloproteinases in breast cancer.
Wieczorek E, Reszka E, Gromadzinska J, Wasowicz W. Wieczorek E, et al. Neoplasma. 2012;59(3):237-47. doi: 10.4149/neo_2012_031. Neoplasma. 2012. PMID: 22296495 Review.
MMPs, fulfilling its function of degradation of extracellular matrix components, are involved in one of the stages of angiogenesis enabling the development, growth and spread of the primary tumor. Therefore, the search for the common polymorphic variants of MMPs, new ge …
MMPs, fulfilling its function of degradation of extracellular matrix components, are involved in one of the stages of angiogenesis enabling …
Association of COMT Val158Met polymorphism and breast cancer risk: an updated meta-analysis.
Qin X, Peng Q, Qin A, Chen Z, Lin L, Deng Y, Xie L, Xu J, Li H, Li T, Li S, Zhao J. Qin X, et al. Diagn Pathol. 2012 Oct 8;7:136. doi: 10.1186/1746-1596-7-136. Diagn Pathol. 2012. PMID: 23039364 Free PMC article. Review.
BACKGROUND: Catechol-O-methyltransferase (COMT) is one of the most important enzymes involved in estrogen metabolism and its functional genetic polymorphisms may be associated with breast cancer (BC) risk. Many epidemiological studies have been conduct …
BACKGROUND: Catechol-O-methyltransferase (COMT) is one of the most important enzymes involved in estrogen metabolism and its functional g …
Impacts of Cytochrome P450 2D6 (CYP2D6) Genetic Polymorphism in Tamoxifen Therapy for Breast Cancer.
Bezerra LS, Santos-Veloso MAO, Bezerra Junior NDS, Fonseca LCD, Sales WLA. Bezerra LS, et al. Rev Bras Ginecol Obstet. 2018 Dec;40(12):794-799. doi: 10.1055/s-0038-1676303. Epub 2018 Dec 7. Rev Bras Ginecol Obstet. 2018. PMID: 30536272 Free PMC article. Review.
Tamoxifen (TMX) is the main drug used both in pre and postmenopausal women as adjuvant treatment for hormone receptor-positive breast cancer. An important barrier to the use of TMX is the development of drug resistance caused by molecular processes related to gen …
Tamoxifen (TMX) is the main drug used both in pre and postmenopausal women as adjuvant treatment for hormone receptor-positive breast …
Association of Cytidine Deaminase Polymorphism with Capecitabine Effectiveness in Breast Cancer Patients.
Aldeen Majeed AA, Salih Sahib A, Shakir Mahmood H, Kadhim Mohsin K, Fadhl Abbas R. Aldeen Majeed AA, et al. Asian Pac J Cancer Prev. 2023 Dec 1;24(12):4219-4225. doi: 10.31557/APJCP.2023.24.12.4219. Asian Pac J Cancer Prev. 2023. PMID: 38156857 Free PMC article.
In this study, we aimed to investigate the relationship between cytidine deaminase polymorphism and capecitabine efficacy in breast cancer patients. METHODS: One hundred breast cancer patients aged 45 to 75 years were included in this study, all …
In this study, we aimed to investigate the relationship between cytidine deaminase polymorphism and capecitabine efficacy in breas …
Association between Vitamin D receptor (Cdx2, Fok1, Bsm1, Apa1, Bgl1, Taq1, and Poly (A)) gene polymorphism and breast cancer: A systematic review and meta-analysis.
Iqbal MUN, Khan TA. Iqbal MUN, et al. Tumour Biol. 2017 Oct;39(10):1010428317731280. doi: 10.1177/1010428317731280. Tumour Biol. 2017. PMID: 29072133 Free article. Review.
The purpose of this systemic review and meta-analysis was to examine the relationship between VDR gene polymorphisms and breast cancer. Literature was searched through PubMed database, Google scholar, and the web of knowledge from December 2015 to January 201 …
The purpose of this systemic review and meta-analysis was to examine the relationship between VDR gene polymorphisms and breast …
11,787 results
You have reached the last available page of results. Please see the User Guide for more information.

Searches related to "polymorphism breast cancer"